# Zcash ETF: financial statements, quarterly

ZCSH · NYSE · CIK 1720265 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zcsh.md) · [Financials](/companies/zcsh/financials.md) · [Filings](/companies/zcsh/filings.md) · [Insiders](/companies/zcsh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/zcsh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [(2.1)](/filings/0000950170-25-035469.md) | [0.1](/filings/0000950170-25-035469.md) | [0.8](/filings/0001193125-26-104253.md) | [(3.4)](/filings/0001193125-26-104253.md) | [2.8](/filings/0001193125-26-104253.md) | [10.8](/filings/0001193125-26-104253.md) | [(7.2)](/filings/0001193125-26-214629.md) | [0.3](/filings/0001720265-26-000006.md) | [14.2](/filings/0001193125-26-104253.md) | [170](/filings/0001193125-26-104253.md) | [(101)](/filings/0001193125-26-214629.md) | [55.8](/filings/0001720265-26-000006.md) |

- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [8.8](/filings/0000950170-23-058539.md) | [9.0](/filings/0000950170-25-035469.md) | [10.0](/filings/0000950170-24-053048.md) | [7.8](/filings/0000950170-24-089617.md) | [10.8](/filings/0000950170-24-120133.md) | [22.0](/filings/0001193125-26-104253.md) | [15.0](/filings/0000950170-25-062766.md) | [15.3](/filings/0000950170-25-101416.md) | [29.8](/filings/0001193125-25-266955.md) | [200](/filings/0001720265-26-000006.md) | [99.4](/filings/0001193125-26-214629.md) | [155](/filings/0001720265-26-000006.md) |
| Total liabilities | $m | [0.0](/filings/0000950170-23-058539.md) | [0.0](/filings/0000950170-25-035469.md) | [0.0](/filings/0000950170-24-053048.md) | [0.0](/filings/0000950170-24-089617.md) | [0.0](/filings/0000950170-24-120133.md) | [0.0](/filings/0001193125-26-104253.md) | [0.0](/filings/0000950170-25-062766.md) | [0.0](/filings/0000950170-25-101416.md) | [0.0](/filings/0001193125-25-266955.md) | [0.0](/filings/0001720265-26-000006.md) | [0.0](/filings/0001193125-26-214629.md) | [0.0](/filings/0001720265-26-000006.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

Shares outstanding: 4,829,300 at 2026-07-30, from the cover of the [10-Q filed 2026-08-04](/filings/0001720265-26-000006.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.